COMPARITIVE TOXICITY AND METABOLISM OF PYRROLIZIDINE ALKALOIDS IN RUMINANTS AND NONRUMINANT HERBIVORES

1984 ◽  
Vol 64 (5) ◽  
pp. 201-202 ◽  
Author(s):  
P. R. CHEEKE

The toxicity of tansy ragwort (Sencio jacobaea) to several ruminant and nonruminant species was tested. Cattle and horses were susceptible (lethal dose of tansy ragwort (TR) was 4–8% of body weight) whereas sheep and goats were resistant (lethal dose of TR was 200–300% of body weight). Other nonruminant herbivoires (rabbits, gerbils, guinea pigs, hamsters) were resistant to TR. Incubation of TR in sheep rumen fluid did not alter its toxicity to rats. No 1-methylene pyrrolizidine alkaloid (PA) derivatives were detected in TR incubated in sheep rumen fluid. The activities of PA-metabolizing enzymes in sheep liver were not influenced by dietary TR. Key words: Pyrrolizidine alkaloids, ruminants, nonruminant herbivores

1970 ◽  
Vol 21 (3) ◽  
pp. 493 ◽  
Author(s):  
GW Lanigan ◽  
LW Smith

In vitro studies have demonstrated that the rate of metabolism of pyrrolizidine alkaloids in sheep's rumen fluid varies greatly. Fluids from sheep at pasture display much higher activity than do those from chaff-fed animals. Addition of dried Heliotropium europaeum to a chaff ration leads to a marked increase in the in vitro rate of alkaloid degradation by the rumen fluid but activity rapidly declines again when the H. europaeum is withdrawn. Thus a major factor limiting multiplication in the rumen of bacteria responsible for alkaloid breakdown appears to be lack of their specific substrates. N-oxides of pyrrolizidine alkaloids are rapidly reduced to tertiary bases in rumen fluid, even in samples from sheep not previously exposed to these substrates. The stimulation of the alkaloid-metabolizing system by vitamin B12 also varies greatly, both in whole rumen fluid and in fluids with activity reduced by removal of coarsely particulate matter. It is concluded that the B12 effect is not related to a specific requirement of the alkaloid-utilizing bacteria but to stimulation of other species which produce a metabolite essential for pyrrolizidine alkaloid metabolism.


1984 ◽  
Vol 35 (2) ◽  
pp. 293 ◽  
Author(s):  
CCJ Culvenor ◽  
MV Jago ◽  
JE Peterson ◽  
LW Smith ◽  
AL Payne ◽  
...  

Groups of 10 Merino wethers were pen-fed pelleted diets containing 80 or 20% Echium plantagineum, for four periods of 12 weeks alternating with four similar periods on control diet. Mild liver damage, characteristic of pyrrolizidine alkaloid poisoning, aas induced in one wether consuming 80% E. plantagineum. The other animals on the 80% diet showed only a small increase in the size of the hepatocytes, which was not unequivocally due to alkaloids. There were no effects on liver function, serum enzymes, weight gain or wool growth attributable to alkaloids. The 80 and 20% Echium diets contained 0.11-0.15 and 0.032-0.047% alkaloid respectively, indicating that approximately onequarter to one-third of the alkaloid of the fresh plant was lost during diet preparation and storage. Echlum feeding induced a high rate of destruction of pyrrolizidine alkaloids in the sheep rumen. The conversion of the Echium alkaloids into pyrrolic metabolites by microsomal preparations from livers of the experimental sheep taken at necropsy was unaffected by the feeding schedule.


1985 ◽  
Vol 65 (3) ◽  
pp. 647-652 ◽  
Author(s):  
K.-J. CHENG ◽  
R. C. PHILLIPPE ◽  
G. C. KOZUB ◽  
W. MAJAK ◽  
J. W. COSTERTON

Nitrate, given intraruminally (0.1 g NO−3 per kg of body weight) to cattle, stimulated the capacity of the rumen microflora to degrade nitrite (NO−2) and nitrate in vitro. Threefold to fourfold increases in rates of NO−2 and NO−3 reduction were observed during NO−3 treatment. The treatment also appeared to stimulate nitropropanol degradation but this effect was less pronounced. The enhanced capacity of rumen microbes to degrade NO−2 and NO−3 was transferred to noninduced (untreated) animals housed in adjacent pens. The transfer of induced metabolism was not observed when induced animals were widely separated from the noninduced ones. This apparent transfer of microbial activities between adjacent animals may complicate studies in which treated and control animals are not separately housed. Key words: Nitrate, nitrite, nitropropanol, induction, degradation, cattle


1919 ◽  
Vol 30 (5) ◽  
pp. 437-453 ◽  
Author(s):  
Louise Pearce ◽  
Wade H. Brown

N-PhenyIglycineamide-p-arsonic acid is an agent of marked therapeutic action in the treatment of experimental trypanosomiasis of mice, rats, and guinea pigs. It possesses an average curative range of from 0.2 to 0.3 gm. per kilo of body weight of the sodium salt against a 24 hour infection in mice and rats produced by several species of pathogenic trypanosomes. Since the lethal dose for mice is from 2 to 2.25 gm. and for rats 0.75 gm. per kilo of body weight, we have curative ratios of 1:8 and 1:3 respectively. The curative dose for guinea pigs is 0.15 gm. per kilo of body weight, thus giving a curative ratio of 1:10. The trypanocidal activity of this compound is relatively rapid in all three animal species, for the peripheral blood is cleared of organisms within 24 hours after its administration, and in addition, the lower limits of the curative range are comparatively sharply defined. Intraperitoneal, intravenous, and subcutaneous routes of administration for all practical purposes may be considered equally efficacious in Tr. brucei infections of mice both as regards the speed of action of the drug and the average curative range. The administration of the drug in therapeutic amounts in all three animal species is not followed by manifestations of organic or functional injury, but, on the contrary, the genera] physical condition of the treated animals shows an immediate and continued marked improvement. The therapeutic activity in trypanosomiasis of mice, rats, and guinea pigs as evidenced by the relative speed and sharpness of action, together with the curative ratio as expressed in fractions of the minimum lethal dose, and the absence of organic injury or functional disturbance following therapeutic doses are significant and characteristic features of the amide of N-phenylglycine-p-arsonic acid.


1920 ◽  
Vol 32 (4) ◽  
pp. 381-400 ◽  
Author(s):  
Hideyo Noguchi

In several series of experiments guinea pigs were variously infected with different amounts of Leptospira icteroides, either in the form of culture, organ emulsion from infected guinea pigs, or a mixture of both. The infecting materials were of different grades of virulence; in some series the amount given was near a single lethal dose, in others a subminimum lethal dose was given, i.e. causing mild infection with recovery in the majority of animals, and in still others the animals were injected with at least 50 minimum lethal doses of a mixture of a culture and a highly virulent organ emulsion from a guinea pig. The animals were inoculated intraperitoneally, and within about 30 minutes each was injected subcutaneously with a different amount of salvarsan or neosalvarsan. The amounts injected were in most series 0.0005, 0.001, 0.002, 0.005, 0.01, 0.02, and 0.03 gm. per 350 to 450 gm. of body weight, and in one series, in addition to this dosage, 0.00005,0.0001, and 0.0002 gm. were also tried. Among the guinea pigs treated either with salvarsan or with neosalvarsan there were more recoveries than among the controls, but they were not in strict proportion to the amounts of the drugs injected. In the experiments with 50 minimum lethal doses of the infecting material there were several recoveries among those which received 0.001 to 0.002 to 0.003 gm., but all passed through a typical infection with all its symptoms. It is extremely doubtful, therefore, whether salvarsan or neosalvarsan mitigated the severity of the infection. The fact is noteworthy that in the same series of experiments the guinea pigs receiving 0.00005 and 0.0001 gm., or thereabout, of salvarsan died 1 to 2 days sooner than the controls, which died in 6 to 7 days. This suggests a possible earlier injury of the kidneys by the drugs, giving the leptospiras an easier and earlier access to, and localization in this organ. The inefficacy or dubious therapeutic value of salvarsan and neosalvarsan against the experimental icteroides infection of guinea pigs presents a close analogy to the observations already made by several investigators with Leptospira icterohæmorrhagiæ. Several series of test-tube experiments were also made to determine the direct effect of salvarsan and neosalvarsan on Leptospira icteroides cultures. It was found, the injurious effect of alkalinity being eliminated, that the leptospiras remain motile for at least I hour in a concentration weaker than 1:10,000 of salvarsan or 1:1,000 of neosalvarsan. But they become gradually sluggish and succumb to the effect of the drugs at the end of 18 to 24 hours. The highest dilution which killed the leptospira in 18 hours was somewhere near 1:200,000. When added to a culture medium, salvarsan and neosalvarsan both suppressed the growth of icteroides when their concentration in the medium was 1:200,000. Hence these two drugs are highly poisonous for Leptospira icteroides. The serums derived from rabbits which received 0.05 gm. of salvarsan or neosalvarsan per kilo of body weight 1 hour before bleeding proved to be very different from a normal rabbit serum in their behavior toward Leptospira icteroides. In the salvarsanized or neosalvarsanized serums the leptospiras remained active for at least 1 hour but appeared somewhat sluggish at the end of 18 hours, and were all dead and degenerated when examined after 48 hours. On the other hand, the leptospiras mixed with normal rabbit serum lived well and multiplied during the same period of time and under otherwise identical conditions (at 28°C.) To these tubes another portion of culture was added to determine whether or not a rapidly detrimental toxic substance had appeared in the drugged serum while standing for 72 hours, but the organisms remained still active at the end of 1 hour, 24 hours being required to kill them. In another experiment the salvarsanized and neosalvarsanized serums, together with normal serum as a control, were first left standing for 72 hours, after which period a rich culture of icteroides was introduced. The organisms remained uninfluenced for 1 hour in all the serums, but at the end of 24 hours many of those in the drugged serums were dead, and none was left alive at the end of 48 hours. In normal serum they steadily increased in numbers and were all active. It is evident, then, that salvarsan or neosalvarsan introduced intravenously into the body of the rabbit is present in some form in the blood serum drawn at the end of 1 hour. The substance present in such serum has a slowly operating injurious effect upon Leptospira icteroides. The action of the drugs seems to be slower after passage through the animal body than before. If this phenomenon were to take place also in the infected body injected with these drugs, it is obvious that in a rapidly evolving infectious disease like yellow fever the progress of the infection will be too rapid to allow the drugs to exert their beneficial effect upon the course of the disease. In direct contrast to the behavior of salvarsan and neosalvarsan in vivo and in vitro, anti-icteroides immune horse serum in a dose of 0.0001 cc., or 1 cc. of a 1:10,000 dilution, protected guinea pigs from an infection with at least 5,000 minimum lethal doses of icteroides when injected simultaneously, but the same serum failed to exert any injurious effect upon the organism when mixed in vitro in a concentration weaker than 1:2,000. A rapid disintegration resulted with a concentration of 1:20 and almost complete agglutination and degeneration in 1:200. The contrast between chemotherapy, as carried out with salvarsan and neosalvarsan, and serotherapy demonstrated with an immune serum is apparently of considerable practical significance.


1919 ◽  
Vol 30 (5) ◽  
pp. 455-481 ◽  
Author(s):  
Louise Pearce ◽  
Wade H. Brown

In the treatment of experimental trypanosomiasis of rabbits with subsequent appraisal of the value of the therapeutic agent used, there are certain experimental factors including uniform infecting strains of trypanosomes and the observation of general procedures of method and time of inoculation conditioned by the infection itself which must be taken into account. The conspicuous and characteristic clinical signs and symptoms seen in rabbit trypanosomiasis serve as criteria of the severity and duration of the disease, and it is obvious that the infection should be well established before treatment is instituted. For the same reason, before the question of a permanent cure can be established, treated rabbits should be kept under observation for a sufficient period of time, which with the species of organisms that we have used is at least 3 months. The therapeutic results with the amide of N-phenylglycine-p-arsonic acid were obtained in rabbits which showed well marked clinical signs of a definitely established disease, and in many instances the infection was extremely advanced and of prolonged duration. The five species which we have employed, Tr. brucei, Tr.gambiense, Tr. equinum, Tr. equiperdum, and Tr. evansi, are uniformly fatal in rabbits. With the usual acute, actively progressing infection of from I to 2 weeks duration produced by our strain of Tr. brucei, the drug has a curative range of from 0.2 to 0.35 gm. per kilo of body weight, when administered intravenously in single doses, or from one-third to one-half the minimal lethal dose. Of the twenty-nine rabbits treated with doses falling within this range, twenty-five, or 86 per cent, were permanently cured and there were no relapses observed with doses above 0.3 gm. The infection produced by our strain of Tr. gambiense is controlled by a slightly lower dose, since there were no relapses with single doses of 0.3 gm. and a single dose of 0.15 gm. effected a cure in one of three rabbits so treated. The therapeutic experiments with Tr. equinum, Tr. equiperdum, and Tr. evansi are too few to admit of final conclusions, but apparently from the evidence at hand, much the same curative range is operative in Tr. evansi infections, while larger doses or a different system of treatment should have been employed in the treatment of rabbits infected with our strains of Tr. equinum and Tr. equiperdum. In addition to the ultimate curative results obtained with single doses within the curative range, it is important to consider the marked therapeutic action with smaller single doses, as shown by the rapid regression and healing of the clinical lesions of the acute infections produced by all five species of trypanosomes together with a marked improvement in the general physical state of the animal. Moreover, large single doses, above those of the so called curative range, caused no disturbance of a toxic nature and were apparently well borne. A system of repeated dose therapy may be employed with advantage in the treatment of both initial and relapsed infections in rabbits, especially in those instances in which there is induration or even necrosis of tissues with weakness and emaciation of the animal host. The factor of time of repetition or the spacing of doses is in our experience as important as that of size of the dose employed and depends upon the rate, degree, and duration of action of the particular dose of the drug in question. Since the amide of N-phenylglycine-p-arsonic add apparently possesses the power of tissue penetration to a marked degree, it is desirable to give the second dose within a short time after the first in order that it may have a full opportunity for the immediate and complete development of its action. The repetition of small doses such as 0.15 gm. per kilo of body weight on successive or alternate days has given successful results as regards both the immediate regression and healing of lesions and ultimate permanent cures in severe, chronic infections. It is possible, however, to administer increasingly large doses, if this is necessary, since infected as well as normal rabbits exhibit a remarkable tolerance to repeated large doses of the drug. The therapeutic activity of small doses administered intramuscularly is quite comparable with that observed after similar doses given intravenously, as indicated by the rate of regression and healing of clinical lesions, while such effects proceed somewhat more slowly after subcutaneous injections. Permanent cures have been obtained in Tr. brucei infection with intramuscular and subcutaneous administration of single doses of from 0.2 to 0.5 gm. of the drug per kilo of body weight and in other instances with three repeated doses of 0.1 gm. per kilo given intramuscularly. One severely infected rabbit which received 0.75 gm. per kilo per os immediately following a small dose of sodium bicarbonate was also cured. The therapeutic experiments here reported represent only a portion of those carried out with N-phenylglycineamide-p-arsonic acid and the scope of the present paper does not permit a detailed description of the many phases of the experiments or a full discussion of the various factors involved and the results obtained, all of which we hope to publish at some future time.


2018 ◽  
pp. 7-79
Author(s):  
S.Yu. Vdovichenko ◽  
◽  
T.D. Fakhrutdinova ◽  

The objective: depression of obstetric and perinatal complications at pregnant women with pathological increase of body weight during pregnancy on the basis of studying of clinical-functional, endocrinologic, metabolic, morphological features of condition of fetoplacental complex and development of advanced algorithm of treatment-and-prophylactic actions. Materials and methods. We conducted examination of 264 patients who consisted on the account concerning pregnancy in female consultations of Kiev. By a method of selection of 178 women were included in retrospective research and 86 – in prospective. The main group was made by 39 pregnant women with whom led individual discussions, control – 142 women, that received traditional references in female consultation. Results. Use of the algorithm improved by us allows to improve obstetric (decrease of frequency of a preeclampsia by 12.3%; anomalies of a patrimonial deyalnost for 8.4%) and perinatal outcomes (depression of level of an asphyxia at a delivery for 9.4% and post-natal adaptation for 7.8%) deliveries of women with an excessive increase of body weight during pregnancy. Conclusion. The received results grant the right to recommend the algorithm improved by us for wide use in practical health care. Key words: obstetric and perinatal pathology, pathological increase of body weight, prophylaxis.


2018 ◽  
Vol 5 (suppl_1) ◽  
pp. S410-S411
Author(s):  
Shinya Shano ◽  
Keita Fukao ◽  
Takeshi Noshi ◽  
Kenji Sato ◽  
Masashi Sakuramoto ◽  
...  

Abstract Background Baloxavir acid (BXA), an active form of orally available prodrug baloxavir marboxil (BXM, formerly S-033188), is a novel small molecule inhibitor of cap-dependent endonuclease (CEN) of influenza A and B virus, and was recently launched for the treatment of acute and uncomplicated influenza with single dosing of BXM (the trade name XOFLUZA™) in Japan in March 2018. Here, we evaluated the prophylactic efficacy of BXA in mice lethally infected with influenza A virus. Methods T1/2 of BXA in human is more than 10 times longer than that in mice. Therefore, suspension of BXA was subcutaneously administered at 0.8 or 1.6 mg/kg in mice to maintain the plasma concentration of BXA as seen in humans, and then mice were intranasally inoculated with a lethal dose of A/PR/8/34 strain at 48, 72, or 96 hours after the administration of BXA. Survival time and body weight change were then monitored through a 28-day period after virus infection. Mice were euthanized and regarded as dead if their body weights were lower than 70% of the initial body weights according to humane endpoints. Results Single dosing of BXA (1.6 mg/kg) completely eliminated mortality in mice, when the mice were administrated the drug at 48, 72, or 96 hours before virus infection (Figure 1). BXA treatment also significantly prevented body weight loss, consistent with the prolonged survival. Conclusion Prophylactic dosing of BXA exhibited significant protective efficacy against mortality and body weight loss in mice following a lethal infection with influenza A virus. The significant prophylactic efficacy observed in our mouse model suggests the potential utility of BXM for the prophylaxis of influenza in human. Disclosures S. Shano, Shionogi & Co., Ltd.: Employee, Salary. K. Fukao, Shionogi & Co., Ltd.: Employee, Salary. T. Noshi, Shionogi & Co., Ltd.: Employee, Salary. K. Sato, Shionogi & Co., Ltd.: Employee, Salary. M. Sakuramoto, Shionogi & Co., Ltd.: Employee, Salary. K. Baba, Shionogi TechnoAdvance Research & Co., Ltd.: Employee, Salary. T. Shishido, Shionogi & Co., Ltd.: Employee, Salary. A. Naito, Shionogi & Co., Ltd.: Employee, Salary.


1990 ◽  
Vol 68 (8) ◽  
pp. 1131-1135 ◽  
Author(s):  
J. Thom ◽  
A. M. Perks

Lungs from fetal guinea pigs of 61 ± 3 days of gestation were supported in vitro for 3 h, and lung liquid secretion rates were measured by a dye dilution technique based on Blue Dextran 2000. Ten preparations that had received no treatment showed an average secretion rate of 1.12 ± 0.28 mL∙kg−1 body weight∙h−1 during the first hour, and there were no significant changes over the following 2 h. In studies of 54 fetal lungs, furosemide, bumetanide, control ethanol carrier, or saline alone were placed in the supporting medium during the middle hour of the 3-h incubations (ABA design). Furosemide at 10−3 M reduced secretion 83.4 ± 16.8%; at 10−4 and 10−5 M it produced smaller reductions. Bumetanide at 10−3 M usually produced reabsorption (129.9 ± 23.0% reduction), at 10−4 M it reduced secretion 30.9 ± 11.8%, but at 10−5 M it was ineffective. Control carrier and saline were without effect. The ability of the loop diuretics to produce reabsorption of fluid in some preparations suggests the unmasking of an active reabsorptive process. The results also suggest that lung liquid secretion in the fetal guinea pig, as in the sheep, is dependent on a Na+ and Cl− cotransport system.Key words: fetus, lung fluid, bumetanide, furosemide.


Sign in / Sign up

Export Citation Format

Share Document